Back
MicroSectors FANG+ Index -3X Inverse Leveraged ETN Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
21
FNGD
MicroSectors FANG+ Index -3X Inverse Leveraged ETN
Last Price:
$6.44
Seasonality Move:
1.53%
Buy
52
SRPT
Sarepta Therapeutics
Last Price:
$21.99
Seasonality Move:
29.39%
Sell
21
MicroSectors FANG+ Index -3X Inverse Leveraged ETN (FNGD)
is a Sell
Is MicroSectors FANG+ Index -3X Inverse Leveraged ETN a Buy, Sell or Hold?
-
The current MicroSectors FANG+ Index -3X Inverse Leveraged ETN [FNGD] share price is $6.44. The Score for FNGD is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
FNGD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $21.97. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FNGD Stock Price Chart
What is MicroSectors FANG+ Index -3X Inverse Leveraged ETN's stock price today?
-
The MicroSectors FANG+ Index -3X Inverse Leveraged ETN share price today is $6.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FNGD is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $21.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
FNGD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.81 | Buy |
Relative Strength Index (14 RSI): | 34.7 | Sell |
Chaikin Money Flow: | -974026 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.44 - 7.46) | Sell |
Bollinger Bands (100): | (7.24 - 16.34) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.43 | Buy |
Relative Strength Index (14 RSI): | 45.86 | Sell |
Chaikin Money Flow: | 1438684 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.97 - 27.13) | Buy |
Bollinger Bands (100): | (24.62 - 80.5) | Sell |
FNGD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.54 | Sell |
20-day SMA: | 6.79 | Sell |
50-day SMA: | 7.84 | Sell |
200-day SMA: | 13.65 | Sell |
8-day EMA: | 5.65 | Buy |
20-day EMA: | 3.6 | Buy |
50-day EMA: | 1.79 | Buy |
200-day EMA: | 0.5 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.18 | Buy |
20-day SMA: | 18.62 | Buy |
50-day SMA: | 29.72 | Sell |
200-day SMA: | 86.62 | Sell |
8-day EMA: | 16.88 | Buy |
20-day EMA: | 10.62 | Buy |
50-day EMA: | 5.26 | Buy |
200-day EMA: | 1.48 | Buy |
MicroSectors FANG+ Index -3X Inverse Leveraged ETN Earnings Growth & FNGD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.77 per share, a decrease this year of $5.77 per share, and an increase next year of $5.30 per share.
MicroSectors FANG+ Index -3X Inverse Leveraged ETN Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |